Financhill
Sell
21

BDRX Quote, Financials, Valuation and Earnings

Last price:
$1.08
Seasonality move :
-4.1%
Day range:
$1.05 - $1.09
52-week range:
$1.01 - $41.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.12x
P/B ratio:
0.30x
Volume:
408.7K
Avg. volume:
2.4M
1-year change:
-95.5%
Market cap:
$3.1M
Revenue:
$474.1K
EPS (TTM):
-$74.60

Earnings Data

Next earnings date for BDRX
--
Most recent earnings per share
--
Missed by --
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2019 Q2 -- -- -- -$208.17 --
03/31/2019 Q1 -- -- -- -$104.09 --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -$5,107.44 --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -$7,794.30 --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -$6,395.04 --
06/30/2017 Q2 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --

Biodexa Pharmaceuticals PLC Earnings Questions

  • How Much did Biodexa Pharmaceuticals PLC Generate in Revenue Last Quarter?

    Biodexa Pharmaceuticals PLC reported -- worth of top line sales in its most recent quarter.

  • Did Biodexa Pharmaceuticals PLC Beat Earnings Last Quarter?

    Biodexa Pharmaceuticals PLC announced earnings per share of -- which represents a miss of analyst forecast a -- per share.

  • Is Biodexa Pharmaceuticals PLC Profitable?

    Biodexa Pharmaceuticals PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Biodexa Pharmaceuticals PLC EPS Next Year?

    Biodexa Pharmaceuticals PLC's earnings are forecast to decrease from -$12.78 per share to -$0.05 per share next year representing a decrease of -99.59%.

  • When is Biodexa Pharmaceuticals PLC's Earnings Date?

    Currently, Biodexa Pharmaceuticals PLC has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on August 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock